Search - tctmd.com

Displaying 61 - 80 of 155

Sort: Relevancy | Date

Podcast TCTMD Talking Points

Episode 28: The AMULET Observational Study

August 23, 2017

News Conference News

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

Todd Neale

November 04, 2016

News Industry News

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

November 02, 2016

Presentation TCT 2016

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David Hildick-Smith

November 02, 2016

Presentation TCT 2016

Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Jai-Wun Park

November 01, 2016

Presentation TCT 2016

Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!)

Presenter: Andreas Baumbach, David Hildick-Smith, Ted Feldman

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

Presenter: Ted Feldman, David Hildick-Smith, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

Indirect Annuloplasty via the Coronary Sinus II: MVRx

Presenter: Ted Feldman, Scott Lim, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

Presenter: Zahid Amin, Jacqueline Saw, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

Severe AS With Simple and Complex CAD

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, David Hildick-Smith

October 30, 2016

Presentation TCT 2016

Technical Aspects Specific for the Left Main Distal Bifurcation II: Insights From the MITO Registry

Presenter: Philippe Généreux, David Hildick-Smith, Sunao Nakamura

October 30, 2016

Presentation TCT 2016

Technical Aspects Specific for the Left Main Distal Bifurcation I: Lessons From Experience

Presenter: Philippe Généreux, David Hildick-Smith, Nicholas J. Lembo

October 30, 2016

Presentation TCT 2016

Double Stenting With TAP: Step-by-step

Presenter: Philippe Généreux, David Hildick-Smith, Francesco Burzotta

October 30, 2016

Advertisement

Episode 28: The AMULET Observational Study

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients!

Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!)

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Indirect Annuloplasty via the Coronary Sinus II: MVRx

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

Severe AS With Simple and Complex CAD

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide!

Technical Aspects Specific for the Left Main Distal Bifurcation II: Insights From the MITO Registry

Technical Aspects Specific for the Left Main Distal Bifurcation I: Lessons From Experience

Double Stenting With TAP: Step-by-step

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content